Please assess the completion status of the following clinical trial:

Trial Title: Postoperative Pain Protocol Limiting Narcotics for Laparoscopic Hand-assisted Donor Nephrectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* all individuals undergoing laparoscopic donor nephrectomies at Stony Brook Hospital~Exclusion Criteria:~* Patients excluded as a potential kidney donor or surgical candidate (renal failure, cancer, uncontrolled hypertension or diabetes, cognitively impaired adults, children, history of stroke, complicated coronary history or pregnant)~* Patients with a history of chronic pain or chronic pain medication use~* Patients who are undergoing open nephrectomies~* Allergy to NSAID or acetaminophen~* Hepatic disease or elevated transaminases~* Peptic Ulcer Disease~* Probenecid use~* History of traumatic brain injury~* Contraindications of Ketamine Use (recent head trauma, open eye injury or glaucoma)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Ketamine (Type: EXPERIMENTAL): Patients in this group will receive ketamine, morphine PCA and caldolor for pain control
- placebo (Type: PLACEBO_COMPARATOR): Patients in this group receive placebo, morphine PCA, and caldolor for pain control

Based on this trial design, predict the completion outcome and termination type (if applicable).